TET1 modulates trophoblast function by regulation of ODC1 in preeclampsia

Chao Fan1, Yan Kang1, Zhenya Fang1

  • 1Key Laboratory of Maternal & Fetal Medicine of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, 250014, China.

Scientific Reports
|November 1, 2025
PubMed

Preeclampsia (PE) is a pregnancy-specific disease that seriously endangers the health of the pregnant woman and the fetus. DNA hydroxymethylation, an epigenetic modification, plays crucial roles in the development of PE. However, the molecular mechanism remains to be elucidated. TET1 is a DNA demethylase that regulates placental trophoblast function. Herein, we investigated the role of TET1 in PE occurrence. Firstly, we confirmed that the 5-methylcytosine (5-mC) levels were reduced in placental tissues from human PE patients and a mouse PE model, while TET1 expression was upregulated. In an oxidative stress model of HTR8/SVneo cells, knockdown of TET1 partially restored the impaired cell invasion and migration caused by H2O2. To elucidate the mechanism, bioinformatics analysis of TET1-knockdown RNA sequencing and ChIP-seq data identified ornithine decarboxylase (ODC1), a rate-limiting enzyme in the polyamine biosynthesis, as a potential target. Similarly, knockdown of ODC1 alleviated the H2O2-induced dysfunction in HTR8/SVneo cells. Moreover, the CUT&RUN and dual-luciferase assays revealed that TET1 regulates the expression of ODC1 by affecting the methylation level of its promoter. Collectively, these results demonstrate that TET1-mediated DNA hydroxymethylation is associated with the occurrence of PE. This is partially attributed to the regulation of ODC1 through altered promoter methylation, which leads to trophoblast dysfunction and contributes to the development of PE.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K